… Despite the passionate debate over the use of β 2 -adrenoceptor agonists in the … β 2 -adrenoceptor
agonists with long half-lives, also called ultra long-acting β 2 -adrenoceptor agonists (…

… β 2 -adrenoceptor agonist bronchodilators ( β 2 -agonists) are … acting and long-acting β 2
-agonists, such classifications may not … β -adrenoceptor agonists ( β -agonists), one of the oldest …

… agonists and the issues of β-AR blockade and cardioselectivity in patients with comorbid CVD.
We then summarize the current … Finally, we provide a view of the future landscape in terms …

… Atypical b-adrenoceptors or b3-adrenoceptors, which are present … b2-Adrenoceptor agonists
have played a key role in the … We suggest that future clinical studies of b-receptors should …

… It is likely that an approach using muscarinic antagonist β 2 -agonist (MABA) molecules
will provide the best opportunity to develop combinations that combine corticosteroids with 2 …

… Glucocorticoids may also enhance the coupling of β 2 -receptors to G-protein (G s ), thus
enhancing β 2 -agonist effects and reversing the uncoupling of β 2 -receptors that may occur in …

… agonists are now being employed for a variety of therapeutic applications, most involving
actions on receptors … α2-adrenoceptor agonists for these applications, recent gene mutation/…

… We also highlight the additional insights from studies of genes that encode GPCR
signaling or regulatory proteins and discuss current implications and future challenges. These …

… More recent research has revealed that there are genetic variations of the … to β 2 -adrenoceptor
agonists. Thus it was found that in an asthmatic cohort, five different β 2 -adrenoceptor …

… of β agonist use (pharmacogenetics). Finally we comment on what the future may hold for the
use of β agonists in … classes of β agonists available and consider their current clinical use. …